SCOM ($3.30, $40M mkt cap). Future growth driven by state regulations for safe needle disposal and growth in aging population, who may need flu shots and self-injectable medications.
Investor Presentations link:
sharpsinc.com
From F3Q07 Earnings Release:
The demand for the Company’s primary product, the Sharps Disposal by Mail System®, which facilitates the proper and cost-effective disposal of medical waste including hypodermic needles, lancets and other devices or objects used to puncture or lacerate the skin (referred to as "sharps"), has been growing rapidly because of its mail-back convenience and its unique data tracking feature. In addition, the targeted market of small quantity sharps waste generators is expanding with the growing awareness of the need to properly handle sharps medical waste for safety and environmental concerns combined with
the expanding need for self-injectable medications.
Dr. Kunik noted, "We continue to see a number of factors driving the growth of our target market of small quantity generators of sharps. In addition to flu shot and inoculation services, retail chains and pharmacies across the nation continue adding healthcare clinics designed to replace non-emergency visits to doctors’ offices. It is estimated that within the next two years, there will be over 3,000 such clinics in retail settings, up from just a few hundred today. We believe public opinion and patient behavior patterns regarding the proper disposal of medical sharps are changing as a result of new and proposed legislation as well as increased awareness of the proper means of sharps disposal." |
